Results of a study of biochemical profile indicators in children with autism spectrum disorders associated with genetic deficiency of the folate cycle

Authors

1 Research Institute of Experimental and Clinical Medicine; 2 Bogomolets National Medical University , Ukraine
https://orcid.org/0000-0002-6615-3072

Keywords:

immunodiagnostics, immunotherapy, neuropsychiatric disorders, children, diagnostics, therapy

Synopsis

Since pathogenic polymorphic nucleotide substitutions in the genes of the folate and methionine cycles, as shown by the results of a number of recent meta-analyses and systematic reviews of randomized controlled clinical trials, are an associated factor with the ASD phenotype in children, a natural question arises regarding the diagnostic significance of conducting appropriate genetic tests in the routine practice of child clinical psychiatry specialists, as well as which part of the wide spectrum of known biochemical disorders identified in children with ASD is directly and/or indirectly related to genetically determined disorders in the functionally interconnected metabolic cycles of folic acid and methionine. The efforts of a number of research groups are currently focused on solving these key problems, as there is an opportunity to obtain informative and clinically applicable folate-associated laboratory biomarkers for rational prediction, risk assessment, and determination of the severity of the condition of patients with ASD, as well as to provide effective and convenient tools for optimizing family planning processes, preparation for pregnancy and childbirth, prenatal diagnosis, postnatal secondary prevention, and therapy of ASD and a number of related comorbid pathological conditions.

References

Maltsev, D. V. (2019). Immunodeficiency due to genetically determined disturbance of folate cycle in children with autism spectrum disorders. Immunology and Allergology: Science and Practice, 1, 4–22.

Maltsev, D. V. (2018). Evaluation of the immune status in children with autism spectrum disorders associated with genetic folate cycle deficiency. Likarska Sprava, 1-2, 11–23. https://doi.org/10.31640/jvd.1-2.2018(02)

Maltsev, D. (2021). Extended clinical and laboratory phenotype in genetically determined folate cycle deficiency in children with autism spectrum disorders. International Neurological Journal, 5 (99), 5–19. https://doi.org/10.22141/2224-0713.5.99.2018.142958

Al-Mosalem, O. A., El-Ansary, A., Attas, O., Al-Ayadhi, L. (2009). Metabolic biomarkers related to energy metabolism in Saudi autistic children. Clinical Biochemistry, 42 (10-11), 949–957. https://doi.org/10.1016/j.clinbiochem.2009.04.006

Arab, A. H., Elhawary, N. A. (2019). Methylenetetrahydrofolate Reductase Gene Variants Confer Potential Vulnerability to Autism Spectrum Disorder in a Saudi Community. Neuropsychiatric Disease and Treatment, 15, 3569–3581. https://doi.org/10.2147/ndt.s230348

Belardo, A., Gevi, F., Zolla, L. (2019). The concomitant lower concentrations of vitamins B6, B9 and B12 may cause methylation deficiency in autistic children. The Journal of Nutritional Biochemistry, 70, 38–46. https://doi.org/10.1016/j.jnutbio.2019.04.004

Bhatia, P., Singh, N. (2015). Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression. Fundamental & Clinical Pharmacology, 29 (6), 522–528. https://doi.org/10.1111/fcp.12145

Chen, L., Shi, X.-J., Liu, H., Mao, X., Gui, L.-N., Wang, H., Cheng, Y. (2021). Oxidative stress marker aberrations in children with autism spectrum disorder: a systematic review and meta-analysis of 87 studies (N = 9109). Translational Psychiatry, 11 (1). https://doi.org/10.1038/s41398-020-01135-3

El-Ansary, A., Hassan, W. M., Daghestani, M., Al-Ayadhi, L., Ben Bacha, A. (2020). Preliminary evaluation of a novel nine-biomarker profile for the prediction of autism spectrum disorder. PLOS ONE, 15 (1), e0227626. https://doi.org/10.1371/journal.pone.0227626

Frustaci, A., Neri, M., Cesario, A., Adams, J. B., Domenici, E., Dalla Bernardina, B., Bonassi, S. (2012). Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses. Free Radical Biology and Medicine, 52 (10), 2128–2141. https://doi.org/10.1016/j.freeradbiomed.2012.03.011

Gevi, F., Belardo, A., Zolla, L. (2020). A metabolomics approach to investigate urine levels of neurotransmitters and related metabolites in autistic children. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, 1866 (10), 165859. https://doi.org/10.1016/j.bbadis.2020.165859

Guo, B.-Q., Li, H.-B., Ding, S.-B. (2020). Blood homocysteine levels in children with autism spectrum disorder: An updated systematic review and meta-analysis. Psychiatry Research, 291, 113283. https://doi.org/10.1016/j.psychres.2020.113283

Haghiri, R., Mashayekhi, F., Bidabadi, E., Salehi, Z. (2016). Analysis of methionine synthase (rs1805087) gene polymorphism in autism patients in Northern Iran. Acta Neurobiologiae Experimentalis, 76 (4), 318–323. https://doi.org/10.21307/ane-2017-030

Li, B., Xu, Y., Zhang, X., Zhang, L., Wu, Y., Wang, X., Zhu, C. (2020). The effect of vitamin D supplementation in treatment of children with autism spectrum disorder: a systematic review and meta-analysis of randomized controlled trials. Nutritional Neuroscience, 25 (4), 835–845. https://doi.org/10.1080/1028415x.2020.1815332

Li, Y., Qiu, S., Shi, J., Guo, Y., Li, Z., Cheng, Y., Liu, Y. (2020). Association between MTHFR C677T/A1298C and susceptibility to autism spectrum disorders: a meta-analysis. BMC Pediatrics, 20 (1). https://doi.org/10.1186/s12887-020-02330-3

Li, Y.-J., Li, Y.-M., Xiang, D.-X. (2017). Supplement intervention associated with nutritional deficiencies in autism spectrum disorders: a systematic review. European Journal of Nutrition, 57 (7), 2571–2582. https://doi.org/10.1007/s00394-017-1528-6

Lv, M., Zhang, H., Shu, Y., Chen, S., Hu, Y., Zhou, M. (2016). The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China. Translational Neuroscience, 7 (1), 6–11. https://doi.org/10.1515/tnsci-2016-0002

Mead, J., Ashwood, P. (2015). Evidence supporting an altered immune response in ASD. Immunology Letters, 163 (1), 49–55. https://doi.org/10.1016/j.imlet.2014.11.006

Melamed, I. R., Heffron, M., Testori, A., Lipe, K. (2018). A pilot study of high‐dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation. Autism Research, 11 (3), 421–433. https://doi.org/10.1002/aur.1906

Shaik Mohammad, N., Sai Shruti, P., Bharathi, V., Krishna Prasad, C., Hussain, T., Alrokayan, S. A. et al. (2016). Clinical utility of folate pathway genetic polymorphisms in the diagnosis of autism spectrum disorders. Psychiatric Genetics, 26 (6), 281–286. https://doi.org/10.1097/ypg.0000000000000152

Noriega, D. B., Savelkoul, H. F. J. (2013). Immune dysregulation in autism spectrum disorder. European Journal of Pediatrics, 173 (1), 33–43. https://doi.org/10.1007/s00431-013-2183-4

Pu, D., Shen, Y., Wu, J. (2013). Association between MTHFR Gene Polymorphisms and the Risk of Autism Spectrum Disorders: A Meta‐Analysis. Autism Research, 6 (5), 384–392. https://doi.org/10.1002/aur.1300

Rai, V. (2016). Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility. Metabolic Brain Disease, 31 (4), 727–735. https://doi.org/10.1007/s11011-016-9815-0

Rai, V. (2017). Strong Association of C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene With Nosyndromic Cleft Lip/Palate (nsCL/P). Indian Journal of Clinical Biochemistry, 33 (1), 5–15. https://doi.org/10.1007/s12291-017-0673-2

Sadeghiyeh, T., Dastgheib, S. A., Mirzaee-Khoramabadi, K., Morovati-Sharifabad, M., Akbarian-Bafghi, M. J., Poursharif, Z. et al. (2019). Association of MTHFR 677C>T and 1298A>C polymorphisms with susceptibility to autism: A systematic review and meta-analysis. Asian Journal of Psychiatry, 46, 54–61. https://doi.org/10.1016/j.ajp.2019.09.016

Wan, L., Li, Y., Zhang, Z., Sun, Z., He, Y., Li, R. (2018). Methylenetetrahydrofolate reductase and psychiatric diseases. Translational Psychiatry, 8(1). https://doi.org/10.1038/s41398-018-0276-6

Wang, Z., Ding, R., Wang, J. (2020). The Association between Vitamin D Status and Autism Spectrum Disorder (ASD): A Systematic Review and Meta-Analysis. Nutrients, 13 (1), 86. https://doi.org/10.3390/nu13010086

Yektaş, Ç., Alpay, M., Tufan, A. E. (2019). Comparison of serum B12, folate and homocysteine concentrations in children with autism spectrum disorder or attention deficit hyperactivity disorder and healthy controls. Neuropsychiatric Disease and Treatment, 15, 2213–2219. https://doi.org/10.2147/ndt.s212361

Downloads

Pages

19-29

Published

May 19, 2025

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Details about the available publication format: PDF

PDF

ISBN-13 (15)

978-617-8360-21-4

How to Cite

Results of a study of biochemical profile indicators in children with autism spectrum disorders associated with genetic deficiency of the folate cycle. (2025). In D. Maltsev, IMMUNODIAGNOSTICS AND IMMUNOTHERAPY OF NEUROPSYCHIATRIC DISORDERS IN CHILDREN (pp. 19–29). Kharkiv: TECHNOLOGY CENTER PC. https://doi.org/10.15587/978-617-8360-21-4.ch2